Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
  • C07K7/04—Linear peptides containing only normal peptide links
  • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
  • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
  • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/08—Solutions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
  • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
  • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
  • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
  • C07K5/10—Tetrapeptides
  • C07K5/1002—Tetrapeptides with the first amino acid being neutral
  • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
  • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
  • C07K7/04—Linear peptides containing only normal peptide links
  • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Molecular Biology (AREA)
• Biochemistry (AREA)
• Biophysics (AREA)
• Genetics & Genomics (AREA)
• Epidemiology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Diabetes (AREA)
• Endocrinology (AREA)
• Dermatology (AREA)
• Obesity (AREA)
• Urology & Nephrology (AREA)
• Hematology (AREA)
• Rheumatology (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Peptides Or Proteins (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Medicinal Preparation (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Applications Claiming Priority (4)

Publications (2)

Family

ID=43527590

Family Applications (1)

Country Status (29)

Families Citing this family (33)

Family Cites Families (54)

• 2010
  • 2010-07-29 SM SM20170014T patent/SMT201700014T1/it unknown
  • 2010-07-29 HU HUE10805078A patent/HUE030960T2/en unknown
  • 2010-07-29 SI SI201031894T patent/SI3192520T1/sl unknown
  • 2010-07-29 PL PL16190682T patent/PL3192520T3/pl unknown
  • 2010-07-29 PT PT16190682T patent/PT3192520T/pt unknown
  • 2010-07-29 CN CN201710873189.9A patent/CN107674114B/zh active Active
  • 2010-07-29 SG SG2012006185A patent/SG178143A1/en unknown
  • 2010-07-29 SM SM20190307T patent/SMT201900307T1/it unknown
  • 2010-07-29 ES ES10805078.2T patent/ES2607954T3/es active Active
  • 2010-07-29 HU HUE16190682A patent/HUE043838T2/hu unknown
  • 2010-07-29 SI SI201031337A patent/SI2459208T1/sl unknown
  • 2010-07-29 KR KR1020127004785A patent/KR101781841B1/ko active Active
  • 2010-07-29 ES ES16190682T patent/ES2729051T3/es active Active
  • 2010-07-29 CN CN201080045024.9A patent/CN102711789B/zh active Active
  • 2010-07-29 DK DK16190682.1T patent/DK3192520T3/da active
  • 2010-07-29 EP EP19159337.5A patent/EP3539555B1/en active Active
  • 2010-07-29 US US12/846,724 patent/US8999932B2/en active Active
  • 2010-07-29 LT LTEP10805078.2T patent/LT2459208T/lt unknown
  • 2010-07-29 PL PL10805078T patent/PL2459208T3/pl unknown
  • 2010-07-29 JP JP2012523061A patent/JP5270799B2/ja active Active
  • 2010-07-29 PT PT108050782T patent/PT2459208T/pt unknown
  • 2010-07-29 DK DK10805078.2T patent/DK2459208T3/en active
  • 2010-07-29 EP EP16190682.1A patent/EP3192520B1/en active Active
  • 2010-07-29 EP EP22193946.5A patent/EP4154900B1/en active Active
  • 2010-07-29 RU RU2012107428A patent/RU2557654C3/ru active
  • 2010-07-29 LT LTEP16190682.1T patent/LT3192520T/lt unknown
  • 2010-07-29 NZ NZ597922A patent/NZ597922A/en unknown
  • 2010-07-29 EP EP20209086.6A patent/EP3808363B1/en active Active
  • 2010-07-29 WO PCT/US2010/043792 patent/WO2011014707A2/en not_active Ceased
  • 2010-07-29 HR HRP20161614TT patent/HRP20161614T1/hr unknown
  • 2010-07-29 BR BR112012002143A patent/BR112012002143B8/pt active IP Right Grant
  • 2010-07-29 EP EP10805078.2A patent/EP2459208B1/en active Active
  • 2010-07-29 MX MX2012001213A patent/MX2012001213A/es active IP Right Grant
  • 2010-07-29 CA CA2769525A patent/CA2769525C/en active Active
  • 2010-07-29 SM SM201700014T patent/SMT201700014B/it unknown
  • 2010-07-29 SG SG10201406921SA patent/SG10201406921SA/en unknown
  • 2010-07-29 TW TW099125105A patent/TWI520744B/zh active
  • 2010-07-29 AU AU2010278897A patent/AU2010278897B2/en active Active
• 2012
  • 2012-01-26 IL IL217749A patent/IL217749A/en active Protection Beyond IP Right Term
  • 2012-01-30 ZA ZA2012/00726A patent/ZA201200726B/en unknown
  • 2012-02-02 US US13/365,213 patent/US8377880B2/en active Active
• 2013
  • 2013-02-18 US US13/769,744 patent/US9278995B2/en active Active
  • 2013-05-09 JP JP2013099331A patent/JP5764613B2/ja active Active
• 2014
  • 2014-02-10 JP JP2014023488A patent/JP2014094967A/ja active Pending
• 2015
  • 2015-03-04 US US14/639,020 patent/US9567370B2/en active Active
• 2016
  • 2016-02-08 US US15/018,567 patent/US9701712B2/en active Active
  • 2016-12-27 CY CY20161101349T patent/CY1118388T1/el unknown
• 2017
  • 2017-01-09 US US15/402,133 patent/US20170114095A1/en not_active Abandoned
  • 2017-03-01 HU HUS1700008 patent/HUS1700008I1/hu unknown
  • 2017-03-09 LU LU00008C patent/LUC00008I2/fr unknown
  • 2017-03-10 LT LTPA2017007C patent/LTC2459208I2/lt unknown
  • 2017-03-16 CY CY2017010C patent/CY2017010I1/el unknown
  • 2017-03-17 FR FR17C1009C patent/FR17C1009I2/fr active Active
  • 2017-05-05 NO NO2017021C patent/NO2017021I1/no unknown
  • 2017-06-21 US US15/629,536 patent/US10280198B2/en active Active
• 2019
  • 2019-03-11 US US16/298,902 patent/US20190194252A1/en not_active Abandoned
  • 2019-05-17 HR HRP20190923TT patent/HRP20190923T1/hr unknown
  • 2019-05-31 CY CY20191100579T patent/CY1121922T1/el unknown
• 2020
  • 2020-09-02 US US17/010,773 patent/US20200399309A1/en not_active Abandoned
• 2022
  • 2022-10-04 US US17/960,060 patent/US20240116983A1/en not_active Abandoned
• 2025
  • 2025-01-16 US US19/025,984 patent/US20250163103A1/en active Pending

Also Published As

Similar Documents